首页 | 本学科首页   官方微博 | 高级检索  
文章检索
  按 检索   检索词:      
出版年份:   被引次数:   他引次数: 提示:输入*表示无穷大
  收费全文   10531篇
  免费   394篇
  国内免费   316篇
耳鼻咽喉   2099篇
儿科学   336篇
妇产科学   153篇
基础医学   796篇
口腔科学   269篇
临床医学   759篇
内科学   986篇
皮肤病学   76篇
神经病学   731篇
特种医学   302篇
外科学   966篇
综合类   1350篇
预防医学   562篇
眼科学   471篇
药学   986篇
  6篇
中国医学   156篇
肿瘤学   237篇
  2024年   21篇
  2023年   231篇
  2022年   331篇
  2021年   508篇
  2020年   401篇
  2019年   480篇
  2018年   422篇
  2017年   291篇
  2016年   315篇
  2015年   246篇
  2014年   830篇
  2013年   646篇
  2012年   595篇
  2011年   738篇
  2010年   553篇
  2009年   523篇
  2008年   503篇
  2007年   491篇
  2006年   456篇
  2005年   380篇
  2004年   321篇
  2003年   232篇
  2002年   154篇
  2001年   167篇
  2000年   154篇
  1999年   164篇
  1998年   108篇
  1997年   103篇
  1996年   71篇
  1995年   82篇
  1994年   84篇
  1993年   52篇
  1992年   47篇
  1991年   44篇
  1990年   44篇
  1989年   32篇
  1988年   47篇
  1987年   33篇
  1986年   37篇
  1985年   61篇
  1984年   58篇
  1983年   32篇
  1982年   32篇
  1981年   27篇
  1980年   31篇
  1979年   18篇
  1978年   15篇
  1977年   12篇
  1976年   4篇
  1974年   4篇
排序方式: 共有10000条查询结果,搜索用时 29 毫秒
991.
目的探讨先天性阴道斜隔综合征(OVSS)临床特征及影像学诊断价值。 方法回顾性分析2017年1月至2022年4月在北京协和医院手术的102例OVSS患者的临床及影像资料,以手术及病理结果为诊断标准,总结分析不同类型OVSS的临床特征及超声和MRI诊断结果。 结果102例OVSS患者中,Ⅰ型30例,Ⅱ型43例,Ⅲ型15例,Ⅳ型14例。Ⅰ型的发病年龄及初潮至发病时间间隔均显著小于其他3种类型(P均<0.05)。痛经及腹痛在Ⅰ型(83.33%)及Ⅳ型(100.00%)的发生率明显高于Ⅱ型(44.19%)及Ⅲ型(40.00%),差异均有统计学意义(P均<0.05)。月经淋漓不尽在Ⅲ型(46.67%)的发生率明显高于Ⅰ型(10.00%)及Ⅳ型(0),差异均有统计学意义(P均<0.05)。阴道脓性分泌物在Ⅱ型(25.58%)的发生率明显高于Ⅰ型(0),差异有统计学意义(P<0.05)。右侧阴道斜隔56例(56/102,54.90%),均合并右肾缺如(54.90%);左侧阴道斜隔46例(46/102,45.1%),伴有左肾缺如43例(42.16%),左肾发育不良1例(0.98%)。102例患者均进行了超声检查,超声正确诊断双子宫双宫颈92例,正确诊断完全型纵隔子宫7例,超声诊断与手术符合率为97.06%(99/102)。82例进行了MRI检查,MRI正确诊断双子宫72例,正确诊断完全型纵隔子宫5例,MRI诊断与手术符合率为93.90%(77/82)。所有102例均进行了阴道斜隔切除术治疗,其中55.88%(57/102)进行了腹腔镜探查联合阴道斜隔切除术,19.61%(20/102)切除患侧子宫。Ⅳ型卵巢子宫内膜异位囊肿的发生率显著高于Ⅰ型及Ⅱ型(P均<0.05)。Ⅳ型采用的腹腔镜探查联合阴道斜隔切除术及患侧子宫切除术明显多于其他3型(P均<0.05)。 结论不同分型的OVSS临床特征有所不同,超声与MRI均可较好地早期诊断OVSS及其并发症,为手术方案的选择提供重要信息。  相似文献   
992.
Because of the presence of an enkephalin-related substance in the somatostatin terminals of the median eminence, an investigation was carried out on the staining for enkephalin of the somatostatin-containing perikarya localized in the hypothalamic periventricular nucleus. Only an occasional and weak enkephalin immunoreactivity was detected in these perikarya, making the common synthesis of the two peptides unlikely. Moreover, our results demonstrate an enkephalin staining in other fibers of the median eminence clearly distinct from the somatostatin ones. Enkephalin was demonstrated in perikarya distributed in the septum, preoptic area, dorsal and ventromedial hypothalamus, all regions known to possibly project into the median eminence. In none of these sites was enkephalin found in association with somatostatin. The present morphological results support the hypothesis that enkephalins may exert their GH-releasing effect at the hypothalamic level and suggest that enkephalins might directly modulate the somatostatin release into the blood of the portal plexus.  相似文献   
993.
Somatostatin (SRIF) content of several brain structures was evaluated by radioimmunoassay in rats bearing various types of hypothalamic transections, as well as lesions of the amygdala. Analysis of the regional changes in SRIF concentrations after surgery suggest the following conclusions: (1) hypothalamic somatostatinergic neurons project to the limbic system, with the exception of the amygdaloid nuclei; (2) the olfactory tubercle, the lateral septal nucleus, the habenula and probably the hippocampus receive somatostatin projections from periventricular SRIF-containing cells; (3) somatostatin-containing fibers take a lateral course after leaving periventricular cells and join the medial forebrain bundle; (4) somatostatin innervation of the amygdala seems to be intrinsic.  相似文献   
994.
BACKGROUND: Obstructive sleep apnea (OSA) has been linked to cardiovascular complications such as stroke and myocardial infarction. Previous studies demonstrate that OSA patients show elevated fibrinogen levels and increased platelet aggregation that are reversed with 1 night of nasal continuous positive airway pressure treatment (NCPAP). Questioning overall coagulability in OSA, we examined whole blood coagulability in 11 chronically NCPAP treated OSA subjects, 22 previously untreated OSA subjects, and in 16 of these after 1 night of NCPAP treatment. PATIENTS AND METHODS: During full polysomnography, subjects from each group had blood drawn prior to bedtime (21:00 h) and upon waking in the morning (07:00 h). RESULTS: Untreated OSA patients had faster P.M. clotting times than chronically treated OSA patients (3.33+/-0.31 versus 6.12+/- 0.66 min, P<0.05 by ANOVA). A.M. values showed similar results (4.31+/- 0.34 min versus 7.08+/-0.52 min, P<0.05 by ANOVA) for the respective groups. One overnight treatment with nasal CPAP did not produce a significant change in A.M. whole blood coagulability (4.35 +/-0.43 to 5.31+/-0.53 min; n=16; P=0.1) in 16 treated subjects. CONCLUSIONS: These data indicate a relationship between obstructive sleep apnea and blood hypercoagulability status that appears to be reversed by chronic NCPAP treatment. These data suggest that NCPAP might protect against the development of cardiovascular complications in OSA patients.  相似文献   
995.
Post-mortem studies have demonstrated a decreased number of glia, reduced glial density, and a decreased glia/neuron ratio in different brain areas of patients diagnosed with a major depressive disorder (MDD). Researchers have therefore suggested that neurotrophic growth factor systems might be involved in the aetiology of MDD. This study aimed to test whether glial cell line-derived neurotrophic factor (GDNF), a member of the transforming growth factor beta family, in serum was associated with MDD. Serum concentrations were measured in MDD patients before treatment (n=76), after 8 weeks of antidepressant treatment (n=39), and in control subjects (n=50) using a sandwich ELISA method. Serum GDNF was significantly lower in MDD patients before treatment than in control subjects (P<0.001). From baseline to remission after 8 weeks of treatment, the increase in serum GDNF was statistically significant (P<0.001). The present study suggests that lower serum GDNF might be involved in the pathophysiology of MDD and antidepressant treatment increases the GDNF in MDD.  相似文献   
996.
Background: This study aimed to investigate the lacrimal flow in patients affected by septal deviations and turbinate hypertrophy and to evaluate changes after rhinoseptoplasty with dacryocystography (DCT) and computed tomographic dacryocystography (CT-DCT). Methods: The study prospectively recruited patients having septal deviations with or without turbinate hypertrophy who underwent surgical evaluation for correction of their respiratory symptoms and were not referred for epiphora. Patients were excluded if they had undergone surgery for cranial vault defects or had experienced septal deviations after traumatic accidents. All patients were studied with DCT and CT-DCT preoperatively and postoperatively. Results: A total of 24 patients (10 men and 14 women) were recruited for the study. Of these patients, 11 (45.8%) had a reduced flow of the medium contrast due to a partial obstruction at the level of the internal ostium. All 11 patients had septal deviations and turbinate hypertrophy, whereas 8 patients had a unilateral obstruction (72.7%), and 3 patients had a bilateral obstruction (27.3%). All flows were corrected after surgery. Conclusions: The safe and well-tolerated radiologic techniques performed in this study provided detailed imaging of the lacrimal outflow system. A high incidence of partial obstruction to the internal ostium was found in patients with septal deviations, turbinate hypertrophy, and no lacrimal symptoms, suggesting a frequent presymptomatic condition.  相似文献   
997.
Antimalarial activity of alkaloids isolated from Stephania rotunda   总被引:2,自引:0,他引:2  
Stephania rotunda (Menispermaceae) is used in traditional medicine for the treatment of fever. Four major alkaloids: dehydroroemerine, tetrahydropalmatine, xylopinine, cepharanthine as well as aqueous extract (SA), dichloromethane extracts (SD1 and SD2) from this plant were tested against Plasmodium falciparum W2 in vitro. Dehydroroemerine, cepharanthine and SD1 were the most active against W2 with IC(50) of 0.36, 0.61microM and 0.7microg/mL, respectively. Their IC(50) on human monocytic THP1 cells were 10.8, 10.3microM and >250microg/mL, respectively. Cepharanthine, SD1 and SA were selected for in vivo antimalarial test against Plasmodium berghei in mice. The results of SD1 and SA at dose of 150mg/kg showed a decrease of 89 and 74% of parasitaemia by intra-peritoneal injection and 62.5 and 46.5% of parasitaemia by oral administration, respectively. The result of cepharanthine at dose of 10mg/kg showed a decrease of 47% of parasitaemia by intra-peritoneal injection and 50% of parasitaemia by oral administration. Drug interaction of chloroquine and major alkaloids indicates that cepharanthine-chloroquine and tetrahydropalmatine-xylopinine associations are synergistic. These results are in agreement with the use of this plant in the treatment of malaria. This is the first report on in vivo antimalarial investigation for Stephania rotunda.  相似文献   
998.
The objectives of this study were to quantitatively evaluate the relationship between frontal craniofacial morphology and the horizontal balance of the lip‐closing forces (LCF) generated during maximum voluntary pursing‐like movements in patients with mandibular deviation. Thirty‐one subjects (median age 25·4 ± 8·9 years) without a history of orthodontic treatment were randomly selected from among the orthodontic patients who visited our hospital. Lip‐closing forces was recorded in eight directions during maximum voluntary pursing‐like lip‐closing movements. The subjects were divided into the deviation (two males and 11 females) and non‐deviation groups (four males and 14 females). There was no significant difference in the total LCF between the deviation and non‐deviation groups. In the deviation group, the mean LCF value on the deviation side of the upper lip was significantly lower than that detected on the non‐deviation side of the upper lip, while the mean LCF value for the deviation side of the lower lip was significantly higher than that for the non‐deviation side of the lower lip. In contrast, no significant difference in upper or lower lip LCF was detected between the deviation and non‐deviation sides in the non‐deviation group. The difference in the LCF generated in the lower lip between the deviation and non‐deviation sides was significantly positively correlated with mandibular menton deviation and significantly negatively correlated with the difference in maxillary height between the deviation and non‐deviation sides. These results suggest that the horizontal balance of the upper and lower lip LCF produced during pursing‐like lip‐closing movements in patients with mandibular deviation is related to frontal craniofacial morphology.  相似文献   
999.
Background: Sonophoresis [low‐frequency ultrasound (US)] has been used in animals and in vitro to investigate enhanced percutaneous absorption of drugs. No study focused on its clinical human tolerance has been published as yet. Methods: We aimed to assess the bioeffects of low‐frequency US in vivo on human skin in a double‐blind randomized‐controlled study. We applied pulse‐mode US at 36 kHz for 5 min in a step procedure of increasing dosage, from 1.57 to 3.50 W/cm2, and placebo. The primary outcome was toxic effects of the procedure, defined as a pain score >40 on a 0–100 mm visual analogue scale or necrosis. Erythema (scored from 0 to 3 in severity) was also evaluated. The secondary outcomes were measurements of skin thickness by high‐resolution skin imaging, of skin capacitance and temperature. Results: We included 34 healthy volunteers. We found no pain score >38 and no skin necrosis with either US or placebo. Erythema was systematically observed immediately after US application, but after 1 day, we observed three cases in the knee group. The most frequent adverse effect was tinnitus. We observed no marked increase in temperature or cutaneous thickness after US or placebo. Cutaneous capacitance increased immediately after both applications. Conclusion: Such data demonstrating good tolerance of sonophoresis can be useful before the initiation of a clinical trial of the therapeutic use of low‐frequency sonophoresis in humans.  相似文献   
1000.
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号